Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abe, A., Radin, N. S., Shayman, J. A., Wotring, L, L., Zipkin, R. E., Sivakumar, R., Ruggieri, J. M., Carson, K. G., and Ganem, B., 1995, Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth. J. Lipid Res. 36: 611–621.
Andrieu, N., Salvayre, R., and Levade, T., 1996, Comparative study of the metabolic pools of sphingomyelin and phosphatidylcholine sensitive to tumor necrosis factor. Eur. J. Biochem. 236: 738–745.
Andrieu-Abadie, N., Carpentier, S., Salvayre, R., and Levade. T., 1998, The tumour necrosis factor-sensitive pool of sphingomyelin is resynthesized in a distinct compartment of the plasma membrane. Biochem J. 333: 91–97.
Avila, M. A., Otero, G., Cansado, J., Dritschilo, A., Velasco, J. A., and Notario, V., 1993, Activation of phospholipase D participates in signal transduction pathways responsive to γ-radiation. Cancer Res. 53: 4474–4476.
Bailly, J. D., Muller, C., Jaffrézou, J. P., Demur, C., Cassar, G., Bordier, C., and Laurent, G., 1995, Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cells. Leukemia 9: 799–807.
Bettaïeb, A., Record, M., Côme, M. G., Bras, A. C., Chap, H., Laurent, G., and Jaffrézou, J. P., 1996, Opposite effects of tumor necrosis factor α on the sphingomyelin-ceramide pathway in two myeloid leukemia cell lines: Role of transverse sphingomyelin distribution in the plasma membrane. Blood 88: 1465–1472.
Bettaïeb, A., Plo, I., Mansat-De Mas, V., Quillet-Mary, A., Levade, T., Laurent, G., and Jaffrézou, J. P., 1999, Daunorubicin and mitoxantrone-triggered phosphatidylcholine hydrolysis: Implication in drug-induced ceramide generation and apoptosis. Mol. Pharmacol. 55: 118–125.
Bezombes, C., Maestre, N., Laurent, G., Levade, T., Bettaïeb, A., and Jaffrézou, J. P., 1998, Restoration of TNF-α-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833. FASEB J. 12: 101–109.
Bezombes, C., Mansat-De Mas, V., Plo, I., Quillet-Mary, A., Nègre-Salvayre, A., Laurent, G. and Jaffrézou, J. P., 2001, Oxidative stress-induced activation of Lyn recruits sphingomyelinase and is requisite for its stimulation by Ara-C FASEB J, 15: 1583–1585.
Bilderback, T. R., Grigsby, R. J., and Dobrowsky, R. T., 1997, Association of p75(NTR) with caveolin and localization of neurotrophin-induced sphingomyelin hydrolysis to caveolae. J. Biol. Chem. 272: 10922–10927.
Brown, D. A., and Rose, J. K., 1992, Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68: 533–544.
Bruno, A. P., Laurent, G., Blaise, R., Averbeck, D., Demur, C., Bonnet, J., Bettaïeb, A., Levade, T., and Jaffrézou, J.P., 1998, Lack of ceramide generation in TF-1 human myeloid leukemic cells resistant to ionizing radiation. Cell Death Diff. 5: 172–182.
Cabot, M. C., Giulano, A. E., Han, T-Y., and Liu, Y-Y., 1999, SDZ PSC 833, the cyclosporin A analog and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells. Cancer Res. 59: 880–885.
Chabner, B. A, and Myers, C. E., 1989, Clinical pharmacology of cancer chemotherapy, in: Cancer: Principles and Practice of Oncology, (V. T. DeVitta, J., Hellman, and S., Rosenberg, S. A.) J. B. Lippencott Co., Philadelphia, PA. pp. 349–395
Chatelut, M., Leruth, M., Harzer, K., Dagan, A., Marchesini, S., Gatt, S., Salvayre, R., Courtoy, P., and Levade T., 1998, Natural ceramide is unable to escape the lysosome, in contrast to a florescent analog. FEBS Lett. 426: 102–106.
Chinnaiyan, A. M., Tepper, C. G., Seldin, M. F., O’Rourke, K., Kischkel, F. C., Hellbardt, S., Krammer, P. H., Peter, M. E., and Dixit, V. M., 1996, FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271: 4961–4965.
Chmura, S. J., Nodzenski, E., Weichselbaum, R. R., and Quintans, J., 1996, Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase. Cancer Res. 56: 2711–2714.
Cocco, L., Maraldi, N. M., and Manzoli, F. A., 1980, Phospholipid interactions in rat liver nuclear matrix. Biochem. Biophys. Res. Commun. 96: 890–898.
Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, J. S., and Spiegel, S., 1996 Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381: 800–803.
Cuvillier, O., Rosenthal, D. S., Smulson, M. E., and Spiegel, S., 1998, Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas-and ceramide-mediated apoptosis in Jurkat T lymphocytes. J. Biol. Chem. 273: 2910–2916.
Dbaido, G. S., Perry, D. K., Gamard, C. J., Platt, R., Poirier, G. G., Obeid, L. M., and Hannun, Y. A., 1997, Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-a: CrmA and Bcl2 target distinct components in the apoptotic pathway. J. Exp. Med, 185: 481–490.
Dive, C., and Hickman, J. A., 1991, Drug-target interactions: only the first step in the commitment to a programmed cell death? Br. J. Cancer 64: 192–196.
Dubrez, L., Savoy, I., Hamman, A., and Solary, E., 1996, Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways. EMBO J. 15: 5504–5512.
Fisher, D. E., 1994, Apoptosis in cancer therapy: crossing the threshold. Cell 78: 539–542.
Fram, R. J., and Kufe, D., 1982, DNA strand breaks caused by inhibitors of DNA synthesis: 1-beta-D-arabinofuranosylcytosine and aphidicolin. Cancer Res. 42: 4050–4053.
Gamard, C.J.L., Dbaibo, G.S., Liu, B., Obeid, L.M. and Hannun, Y.A., 1997, Selective involvement of ceramide in cytokine-induced apoptosis. Ceramide inhibits phorbol ester activation of nuclear factor kappaB. J. Biol Chem., 272: 16474–16481.
Gunji, H., Kharbanda, S., and Kufe, D., 1991, Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-D-arabinofuranosylcytosine. Cancer Res. 51: 741–743.
Haimovitz-Friedman, A., Kan, C. C., Ehleiter, D., Persaud, R. S., McLoughlin, M., Fuks, Z., and Kolesnick, R. N., 1994, Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med. 180: 525–535.
Hampton, R. Y., Morand, O. H., 1989, Sphingomyelin synthase and PKC activation. Science. 246: 1050.
Hannun, Y. A., and Obeid, L. M., 1995, Ceramide: an intracellular signal for apoptosis. Trends Biochem. Sci. 20: 73–77.
Hannun, Y. A., 1997, Apoptois and the dilemma of cancer chemotherapy. Blood 89: 1845–1853.
Hickman, J. A., 1992, Apoptosis induced by anticancer drugs. Cancer and Metastasis Rev. 11: 121–139.
Higuchi, M., and Aggarwal, B. B., 1994, Differential roles of two types of the TNF receptor in TNF-induced cytotoxicity, DNA fragmentation, and differentiation. J. Immunol. 152: 4017–4022.
Higuchi, M., Singh, S., Chan, H., and Aggarwal, B. B., 1995, Protease inhibitors differentially regulate tumor necrosis factor-induced apoptosis, nuclear factor-κB activation, cytotoxicity, and differentiation. Blood 86: 2248–2256.
Huang, M. M., Bolen, J. B., Barnwell, J. W., Shattil, S. J., and Brugge, J. S., 1991, Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets, Proc. Natl. Acad. Sci. USA 88: 7844–7848.
Jaffrézou, J. P., Levade, T., Bettaïeb, A., Andrieu, N., Bezombes, C., Maestre, N., Vermeersch, S., Rousse, A., and Laurent, G., 1996, Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J. 15: 2417–2424.
Jaffrézou, J. P., Bettaïeb, A., Levade, T., and Laurent, G., 1998, Antitumor agent-Induced apoptosis in myeloid leukemia cells: a controlled suicide. Leukemia Lymphoma 29: 453–463
Jaffrézou, J. P., Bruno, A. P., Moisand, A., Levade, T., and Laurent, G., 2001, Activation of a nuclear sphingomyelinase in radiation induced apoptosis. FASEB J. 15: 123–133.
Jarvis, W. D., Fornari, F. A., Browning, J. L., Gewirtz, D. A., Kolesnick, R. N., and Grant, S. G., 1994, Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. J. Biol. Chem. 269: 31685–31692.
Jarvis, W. D., Fornani, F. A., Traylor, R. S., Martin, H. A., Kramer, L. B., Erukulla, R. K., Bittman, R., and Grant, S., 1996, Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells. J. Biol. Chem. 271: 8275–8284.
Kleuser, B., Cuvillier, O., and Spiegel, S., 1998, 1±,25-dihydroyvitamin D3 inhibits programmed cell death in HL-60 cells by activation of sphingosine kinase. Cancer Res. 58: 1817–1824.
Kumar, S., and Harvey, N. L., 1995, Role of multiple cellular proteases in the execution of programmed cell death. FEBS Lett. 375: 169–173.
Lahti, J. M., Xiang, J., Heath, L. S., Campana, D., and Kidd, V.J., 1996, PITSLRE protein kinase activity is associated with apoptosis. Mol. Cell. Biol. 15: 1–11.
Laurent, G., and Jaffrézou, J. P., 2001, Signaling pathways activated by daunorubicin. Blood, 15: in press.
Lavie, Y., Cao, H-t., Bursten, S.L., Giulano, A.E. and Cabot, M.C., 1996, Accumulation of glucosylceramide in multidrug-resistant cancer cells. J. Biol. Chem., 271: 19530–19536.
Lavie, Y., Cao, H-t., Volner, A., Lucci, A., Han, T. Y., Geffen, V., Giuliano, A. E., and Cabot, M. C., 1997, Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J. Biol. Chem. 272: 1682–1687.
Levade, T., and Jaffrézou, J. P., 1999, Signaling sphingomyelinase: which, where, how and why. Biochim. Biophys. Acta, 1438: 1–7.
Linardic, C. M., and Hannun, Y. A., 1994, Identification of a distinct pool of sphingomyelin involved in the sphingomyelin cycle. J. Biol. Chem. 269: 23530–23537.
Liu, P., and Anderson, R. G. W., 1995, Compartmentalized production of ceramide at the cell surface. J. Biol. Chem. 270: 27179–27185.
Liu, J., Oh, P., Horner, T., Rogers, R. A., and Schnitzer, J. E., 1997, Organized endothelial cell surface signal transduction in caveolae distinct from glycosyl phosphatidylinositol-anchored protein microdomains. J. Biol. Chem. 272: 7211–7222.
Liu, Y. Y., Han, T. Y., Giulano, A. E., and Cabot, M. C., 1999, Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J. Biol. Chem. 274: 1140–1146.
Liu, Y-Y., Han, T-Y., Giulano, A. E., Hansen, N., and Cabot, M. C., 2000, Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisens reverses adriamycin resistance. J. Biol. Chem. 275: 7138–7143.
Luberto, C., and Hannun, Y. A., 1998, Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C? J. Biol. Chem. 273: 14550–14559.
Lucci, A., Cho, W.I., Han, T.Y., Giulano, A.E. and Cabot, M.C., 1998, Glucosylceramide: a marker for multdrug-resistant cancers. Anticancer Res., 18: 475–480.
Lucci, A., Han, T. Y., Liu, Y. Y., Giuliano, A. E., and Cabot, M. C., 1999a, Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxins. Int. J. Oncol., 15: 541–546.
Lucci, A., Han, T. Y., Liu, Y. Y., Giuliano, A. E., and Cabot, M. C., 1999b, Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells. Cancer 86: 299–310.
Machleidt, T., Wiegmann, K., Henkel, T., Schütze, S., Baeuerle, P., and Krönke, M., 1994, Sphingomyelinase activates proteolytic lκ-α degradation in a cell-free system. J. Biol. Chem. 269: 13760–13765.
Mansat, V., Laurent, G. Levade, T., Bettaïeb, A., and Jaffrézou, J.P., 1997a, The protein kinase C inhibitors phorbol ester and phosphatidylserine block neutral sphingomyelinase activation, ceramide generation and apoptosis triggered by daunorubicin. Cancer Res. 57: 5300–5304.
Mansat, V., Bettaïeb, A., Levade, T., Laurent, G., and Jaffrézou, J.P., 1997b, Serine-protease inhibitors block neutral sphingomyelinase activation, ceramide generation and apoptosis triggered by daunorubicin. FASEBJ. 11: 695–702.
Martin, S. J., and Green, D. R., 1994, Apoptosis as a goal of cancer therapy. Curr. Opin. Oncol. 6: 616–621.
Martin, S. J., Amarante-Mendes, G. P., Shi, I., Chuang, T. H., Casiano, C. A., O’Brien, G. A., Fitzgerald, P., Tan, E. M., Bokoch, G. M., Greenberg, A. H., and Green, D. R., 1996, The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of thez ICE/CED-3 family protease, CPP32, via novel two-step mechanism. EMBO J. 15: 2407–2416.
Munker, R., DiPersio, J., and Koeffler, H. P., 1987, Tumor necrosis factor: receptors on hematopoietic cells. Blood 70: 1730–1734.
Nicholson, D.W., Ali, A., Thornberre, N.A., Vaillancourt, J.P., Ding, C.K., Gallant, M., Gareau, Y., Griffin, P.R., Labelle, M., Lazenbnik, Y.A., Munday, N.A., Raju, S.M., Smulson, M.E., Yamin, T.T., Yu, V.L. and Miller, D.K., 1995, Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature, 376: 37–43.
Nishio, K., Sugimoto, Y., Fujiwara, Y., Ohmori, T., Morikage, T., Takeda, Y., and Saijo, N., 1992, Phospholipase C-mediated hydrolysis of phosphotidylcholine is activated by cisdiamminedichloroplatinum (II). J. Clin. Invest. 89: 1622–1628.
Nishizuka, Y., 1995, Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9. 484–496.
Obeid, L. M., Linardic, C. M., Karolak, L. A., and Hannun Y. A., 1993, Programmed cell death induced by ceramide. Science. 259: 1769–1771.
Perez, G. I., Knudson, C. M., Leykin, L., Korsmeyer, S. J., and Tilly, J. L., 1997, Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. Nature Med. 3: 1228–1232.
Posada, J., Vichi, P., and Tritton, T. R., 1989, Protein kinase C in adriamycin action and resistance in mouse sarcoma 180 cells. Cancer Res. 49: 6634–6639.
Pronk, G. J., Ramer, K., Amiri, P., and Williams, L. T., 1996, Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 271: 808–810.
Quillet-Mary, A., Mansat, V., Duchayne, E., Côme, M. G., Allouche, M., Bailly, J. D., Bordier, C., and Laurent, G., 1996, Daunorubicin-induced internucleosomal DNA fragmentation in acute myeloid cell lines. Leukemia 10: 417–425.
Quintans, J., Kilkus, J., McShan, C. L., Gottschalk, A. R., and Dawson, G., 1994, Ceramide mediates the apoptotic response of WEHI 231 cells to anti-immunoglobulin, corticosteroids and irradiation. Biochem. Biophys. Res. Commun. 202: 710–714.
Rani, C. S., Abe, A., Chang, Y., Rosenzweig, N., Saltiel, A. R., Radin, N. S., and Shayman, J. A., 1995, Cell cycle arrest induced by an inhibitor of glucosylceramide synthase. Correlation with cyclin-dependent kinases. J. Biol. Chem. 270: 2859–2867.
Rubin, E., Kharbanda, S., Gunji, H., Weichselbaum, R., and Kufe, D., 1992, Cis-diamminedichloroplatinum (II) induces c-jun expression in human myeloid leukemia cells: potential involvement of a PKC-dependent signaling pathway. Cancer Res. 52: 878–882.
Santana, P., Peña, L. A., Haimovitz-Friedman, A., Martin, S., Green, D. R., McLoughlin, M., Cordon-Cardo, C., Schuchman, E. H., Fuks, Z., and Kolesnick, R., 1996, Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86: 189–199.
Ségui, B., Bezombes, C., Uro-Costes, E., Medin, J. A., Andrieu-Abadie, N., Auge, N., Brouchet, A., Laurent, G., Salvayre, R., Jaffrezou, J. P., and Levade, T., 2000, Stress-induced apoptosis is not mediated by endolysosomal ceramide. FASEB J. 14: 36–47.
Shayman, J. A., Deshmukh, G. D., Mahdiyoun, S., Thomas, T. P., Wu, D., Barcelon, F. S., and Radin, N. S., 1991, Modulation of renal epithelial cell growth by glucosylceramide. Association with protein kinase C, sphingosine, and diacylglycerol. J. Biol, Chem. 266: 22968–22974.
Simons, K., and Ikonen, E., 1997, Functional rafts in cell membranes. Nature 387: 569–572.
Spangler, M., Coetzee, M. L., Katyal, S. L., Morris, H. P., and Ove, P., 1975, Some biochemical characteristics of rat liver and morris hepatoma nuclei and nuclear membranes. Cancer Res. 35: 3131–3145.
Strum, J. C., Small, G. W., Pauig, S. B., and Daniel, L. W., 1994, 1-β-d-arabinofuranosyl-cytosine stimulates ceramide and diglyceride formation in HL-60 cells. J. Biol. Chem. 269: 15493–15497.
Smyth, M. J., Perry, D. K., Zhang, J., Poirier, G. G., Hannun, Y. A., and Obeid, L. M., 1996, prICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2. Biochem. J. 316: 25–28.
Tamiya-Koizumi, K., Umekawa, H., Yoshida, S., and Kojima, K., 1989, Existence of Mg2+ dependent, neutral sphingomyelinase in nuclei of rat ascites hepatoma cells. J. Biochem. 106: 593–598
Tepper, A. D., Ruurs, P., Wiedmer, T., Sims, P. J., Borst, J., and van Blitterswijk, W. J., 2000, Sphingomyelin hydrolysis to ceramide during the execution phase of apoptosis results from phospholipid scrambling and alters cell-surface morphology. J. Cell Biol. 150: 155–164.
van Helvoort, A., Smith, A., Sprong, H., Fritzsche, I., Schinkel, A. H., Borst, P., van Meer, G., 1996, MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87: 507–517.
Twentyman, P. R., and Bleehen. N. M., 1991, Resistance modification by PSC-833, a novel nonimmunosuppressive cyclosporin. Eur. J. Cancer 27: 1639–1642.
van Helvoort, A., Giudici, M. L., Thielemans, M., and van Meer, G., 1997, Transport of sphingomyelin to the cell surface is inhibited by brefeldin A and in mitosis, where C6-NBD-sphingomyelin is translocated across the plasma membrane by a multidrug transporter activity. J. Cell Sci. 110: 75–83.
Veldman, R. J., Maestre, N., Aduib, O. M., Medin, J. A., Salvayre, R., and Levade, T., 2001, A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumor necrosis factor signaling. Biochem. J. 355: 859–868.
Wesselborg, S., Engels, I.H., Rossmann, E., Los, M. and Schulze-Osthoff, K., 1999, Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. Blood, 93: 3053–3063.
Wiegmann, K., Schütze, S., Machleidt, T., Witte, D., and Krönke, M., 1994, Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78: 1005–1008.
Wright, S. C., Zheng, H., and Zhong, J., 1996, Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 34 kDa apoptotic protease (AP24). FASEB J. 326: 325–332.
Yuan, Z. M., S. Kharbanda, and D. Kufe., 1995, l-beta-D-arabinofuranosylcytosine activates tyrosine phosphorylation of p34cdc2 and its association with the src-like p56/p53lyn kinase in human myeloid leukemia cells. Biochemistry. 34: 1058–1063.
Zhang, J., Alter, N., Reed, J. C., Borner, C., Obeid, L. M., and Hannun Y. A., 1996, Bcl-2 interrupts the ceramide-mediated pathway odf cell death. Proc. Natl. Acad. Sci. USA 93: 5325–5328.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Kluwer Academic Publishers
About this chapter
Cite this chapter
Jaffrézou, JP., Laurent, G., Levade, T. (2004). Ceramide in Regulation of Apoptosis. In: Quinn, P.J., Kagan, V.E. (eds) Phospholipid Metabolism in Apoptosis. Subcellular Biochemistry, vol 36. Springer, Boston, MA. https://doi.org/10.1007/0-306-47931-1_14
Download citation
DOI: https://doi.org/10.1007/0-306-47931-1_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46782-0
Online ISBN: 978-0-306-47931-1
eBook Packages: Springer Book Archive